Brought to you by:
Shaping the vascular workforce of tomorrow
“I have been a staunch supporter of thinking ambitiously about how we maintain what should be a viable and thriving workforce that doesn’t just address capacity of surgical support but also training for what our patients need — not just our patients of today, but our patients 20 and 30 years from now,” said Dawn Coleman,…
Study explores when AAA surveillance may no longer benefit older patients
New research suggests that surveillance for small abdominal aortic aneurysms (AAA) may not always provide meaningful benefit in older patients, particularly those with significant comorbidities. The data was presented during Plenary Session 5 by Sowmya Mangipudi, MD, MSc. The study…
Rethinking antiplatelet and anticoagulant use in PAD after AQUATIC
During Thursday’s Hot Topics session, John Curci, MD, an associate professor at Vanderbilt Health, discussed the changing landscape of long-term antiplatelet and anticoagulant use in the management of peripheral artery disease (PAD) in light of results from the AQUATIC trial.…
Data support conservative approach to claudication in elderly patients
Claudication rarely takes a limb. But in patients over 80, the attempt to treat it surgically may take something just as important. New data, presented at VAM 2026 by Jeffrey Siracuse, MD, makes the case that for octogenarians with intermittent…
TCAR demonstrates durable long-term outcomes with few reinterventions
Across more than 1,000 transcarotid artery revascularization (TCAR) procedures performed over eight years at a single high-volume institution, a recent study found only 12 patients required reintervention — a 1.1% rate that speaks to the durability of TCAR. The data…
Advances in medical management could redefine PAD care
“Peripheral arterial disease [PAD] should no longer be viewed simply as a problem of arterial obstruction requiring procedural intervention,” said Mohamed Zayed, MD, PhD, associate professor of Surgery and Radiology at Washington University School of Medicine. That assertion cuts to…
Deep vein arterialization challenges notion of ‘no-option’ CLTI
“Patients previously considered ‘no-option’ may no longer truly be without options,” said Anahita Dua, MD, associate professor at Harvard Medical School and a vascular surgeon at Massachusetts General Hospital. That assertion sums up the central finding of an analysis comparing…
DCB therapy reduces MALE rates across femoropopliteal lesion complexity
In an era of expanding device options and the clinical temptation to match procedural complexity to lesion complexity, a new study offers a counterintuitive but data-driven argument: In femoropopliteal disease, doing less may actually deliver more. Research using the Vascular…
Pre-operative guideline adherence tied to fewer major adverse limb events
For patients with claudication, surgical revascularization is meant to restore quality of life. But a new retrospective study finds that most patients are arriving for that intervention without completing the pre-operative care that guidelines recommend and that the shortfall carries…
Tibial access in claudicants linked to guideline-discordant care and CLTI progression
Retrograde tibial access has long offered technical advantages in peripheral vascular procedures, but a new study raises concern that its use in patients with claudication may be driving treatment decisions that exceed what current guidelines recommend, creating a clinically significant…